Crinetics Pharmaceuticals, Inc. (CRNX)
55.99
-0.44
(-0.78%)
USD |
NASDAQ |
Jan 16, 16:00
57.00
+1.01
(+1.80%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap: 5.740B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 11.39B |
| GT Biopharma, Inc. | 7.932M |
| Axsome Therapeutics, Inc. | 8.937B |
| Sutro Biopharma, Inc. | 117.74M |
| Gossamer Bio, Inc. | 583.27M |
Market Cap Related Metrics
| PS Ratio | 3397.72 |
| PEG Ratio | -0.5622 |
| Price to Book Value | 5.353 |
| Price | 55.99 |
| Earnings Yield | -8.10% |
| PEGY Ratio | -0.5622 |